|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R97.8 |
Other abnormal tumor markers
|
R978 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 6.85%
|
24.40%
|
20.70%
|
14.39%
|
9.84%
|
6.58%
|
4.56%
|
3.38%
|
2.37%
|
1.80%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R97.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,816
|
1,819
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,507
|
1,507
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,298
|
1,300
|
|
86301
|
IMMUNOASSAY TUMOR CA 19-9 |
1,199
|
1,200
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
856
|
857
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
575
|
577
|
|
86304
|
IMMUNOASSAY TUMOR CA 125 |
465
|
465
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
404
|
448
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
310
|
29,105
|
|
82105
|
ALPHA-FETOPROTEIN SERUM |
293
|
293
|
|
84153
|
ASSAY OF PSA TOTAL |
283
|
283
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
247
|
247
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
234
|
234
|
|
84443
|
ASSAY THYROID STIM HORMONE |
229
|
230
|
|
80061
|
LIPID PANEL |
204
|
204
|
|
82728
|
ASSAY OF FERRITIN |
186
|
186
|
|
83735
|
ASSAY OF MAGNESIUM |
185
|
185
|
|
85610
|
PROTHROMBIN TIME |
180
|
180
|
|
83540
|
ASSAY OF IRON |
175
|
176
|
|
82565
|
ASSAY OF CREATININE |
166
|
166
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R97.8 related to the following DRG Codes:
947-948
|
